胰島素幫浦市場規模、佔有率、成長分析、按產品類型、按配件、按最終用途、按地區 - 行業預測，2024-2031 年

2022年全球胰島素幫浦市場規模預計為55.9億美元，從2023年的60.5億美元成長到2031年的113.8億美元，預測期（2024-2031）預計複合年成長率為8.22%。

胰島素幫浦市場正在經歷顯著成長，這主要是由於全球範圍內糖尿病（尤其是第 1 型糖尿病）盛行率上升所推動。 2019年，糖尿病患者人數估計為5.37億，預計2045年將達到7.83億人。隨著領先的醫療設備製造商不斷創新並推出整合了人工智慧 (AI) 和機器學習 (ML) 等功能的先進胰島素泵，技術進步也對這一激增進行了補充。這些發展不僅改善了使用者體驗，也提高了治療效果。人們對糖尿病管理和治療方案的認知不斷增強，加上醫療保健成本不斷上升以及醫療設施的改善，使得胰島素幫浦市場將經歷快速成長。此外，預計未來幾年將保持強勁的複合年成長率，這反映了美國市場的情況。這些技術創新和不斷成長的醫療保健需求相結合，凸顯了胰島素幫浦市場的巨大潛力，使其成為糖尿病護理解決方案投資和市場開拓的焦點。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• PESTEL分析
• 技術分析
• 價格分析
• 供應鏈分析

胰島素幫浦市場：按類型

• 市場概況
• 貼片幫浦
• 繫繩幫浦

胰島素幫浦市場：依產品

• 市場概況
• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• 其他

胰島素幫浦市場：依配件分類

• 市場概況
• 胰島素儲液器或藥筒
• 胰島素套插入裝置
• 電池

胰島素幫浦市場：依最終用途分類

• 市場概況
• 醫院/診所
• 居家照護
• 研究所

胰島素幫浦市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic（Ireland）
• Hoffmann-La Roche AG（Switzerland）
• Tandem Diabetes Care, Inc.（US）
• Insulet Corporation（US）
• Ypsomed AG（Switzerland）
• Sanofi SA（France）
• Sooil Development（Korea）
• Jiangsu Delfu Co., Ltd.（China）
• Cellnovo Ltd.（UK）
• Valeritas, Inc.（US）
• Debiotech SA（Switzerland）
• CeQur Simplicity（Switzerland）
• Microtec Medical Ltd.（UK）
• ViCentra BV（Netherlands）
• EOFLOW CO., LTD.（Korea）
• Becton, Dickinson and Company（US）
• Abbott Laboratories（US）
• Braun Melsungen AG（Germany）
• Animus Corporation（US）
• Asante（US）
• Nipro Diagnostic, Inc.（Japan）

Global Insulin Pump Market size was valued at USD 5.59 billion in 2022 and is poised to grow from USD 6.05 billion in 2023 to USD 11.38 billion by 2031, growing at a CAGR of 8.22 % in the forecast period (2024-2031).

The insulin pump market is experiencing significant growth, driven primarily by the rising prevalence of diabetes, especially type 1 diabetes, on a global scale. With an estimated 537 million individuals living with diabetes in 2019-a figure projected to reach 783 million by 2045-there is an increasing demand for portable insulin delivery systems among patients. This surge is complemented by advancements in technology, as leading medical device manufacturers innovate and release sophisticated insulin pumps integrated with features like artificial intelligence (AI) and machine learning (ML). These developments not only enhance user experience but also improve treatment efficacy. As awareness of diabetes management and treatment options expands, coupled with the escalation in healthcare costs and improved access to medical facilities, the market for insulin pumps is positioned for rapid growth. Furthermore, the U.S. insulin pump market is expected to sustain a robust compound annual growth rate (CAGR) in the upcoming years, reflecting a healthy market landscape. This combination of technological innovation and increasing healthcare demands underscores the insulin pump market's promising potential, making it a focal point for investment and development in diabetes care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pump Market Segmental Analysis

Global Insulin Pump Market is segmented on the basis of type, product, accessories, end use, and region. By type, market is segmented into patch pumps, and tethered pumps. By product, market is segmented into MiniMed, Accu-Chek, Tandem, Omnipod, and others. By accessories, market is segmented into insulin reservoir or cartridges, insulin set insertion devices, and battery. By End use, market is segmented into hospitals & clinics, homecare, and laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Insulin Pump Market

The growing adoption of insulin pumps among diabetic patients, both in developed and emerging markets, serves as a significant driver for the global insulin pump market. Market participants are increasingly focusing their research and development efforts on innovative, technologically advanced products to meet this rising demand. The positive outcomes from various clinical trials highlighting improved glucose control in type 2 diabetes patients utilizing pump therapy versus those on Multiple Daily Injection (MDI) therapy further boost market prospects. As patients and healthcare providers seek superior diabetes management solutions, the continuous advancement and introduction of new insulin delivery devices will enhance market growth, fostering improved patient outcomes.

Restraints in the Global Insulin Pump Market

The Global Insulin Pump market faces significant restraints primarily due to limited reimbursement options and the high costs associated with insulin pumps, making them less accessible for patients who heavily rely on financial support for treatment. This is particularly pronounced in underdeveloped and emerging countries, where awareness of diabetes and insulin pump technologies is low, stemming from inadequate healthcare infrastructure. The International Diabetes Federation reported that approximately 232 million diabetics were undiagnosed in 2019, further complicating market penetration. As a result, these financial and awareness barriers hinder the widespread adoption of insulin pump technologies, potentially stalling market growth.

Market Trends of the Global Insulin Pump Market

The Global Insulin Pump market is poised for significant growth, driven by the integration of intelligent technologies such as AI into healthcare IT. This advancement facilitates the development of AI-enabled insulin pumps and automated drug delivery systems, particularly tailored for type 2 diabetes management. As the prevalence of type 2 diabetes continues to rise, there is an increasing demand for technologically advanced insulin pumps, with current adoption rates hovering around 5% and projected to reach approximately 15% by 2027. This shift reflects a broader trend towards innovation in diabetes care, positioning the insulin pump market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• PESTEL Analysis
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis

Insulin Pump Market, By Type

• Market Overview
• Patch pumps
• Tethered pumps

Insulin Pump Market, By Product

• Market Overview
• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• Others

Insulin Pump Market, By Accessories

• Market Overview
• Insulin reservoir or cartridges
• Insulin set insertion devices
• Battery

Insulin Pump Market, By End Use

• Market Overview
• Hospitals & clinics
• Homecare
• Laboratories

Insulin Pump Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sooil Development (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellnovo Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeritas, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Debiotech S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeQur Simplicity (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microtec Medical Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViCentra B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EOFLOW CO., LTD. (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animus Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asante (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Diagnostic, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments